Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs Harbor

By GLP-1 ScorecardUpdated

CoraDocFactor scores not reassessed.
Site position #49

Higher score

HarborFactor scores not reassessed.
Site position #94

Lower score

Score comparison

CoraDoc has the higher recorded score — 76.8/100 to 72/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc advertises one upfront payment for a selected GLP-1 program. Its sales page and written refund policy give different answers about what you may get back.

Before you choose

Before comparing the headline prices, the CoraDoc review and the Harbor review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoraDoc vs Invigor Medical and CoreAge Rx vs Harbor compare each of them with another graded program, and the list of alternatives to CoraDoc ranks the programs closest to CoraDoc on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoraDoc +22
96
74
Dose & formulationCoraDoc +8
72
64
Clinical oversightHarbor +10
79
89
Labs & monitoringHarbor +10
53
63
FulfillmentHarbor +5
76
81
Contract termsCoraDoc +22
69
47
CoraDoc · top barHarbor · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoraDocHarbor
WeighScore76.8/10072/100
GradeCC
Site position#49#94
Semaglutide$924 upfront (12-month promotion, compounded)$99/mo (starting dose, compounded)
Tirzepatide$1,524 upfront (12-month promotion, compounded)$149/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoraDoc

Site position #49 · C

Factor scores not reassessed.

Strengths

  • The 12-month promotion publishes the one-time payment for each medication
  • The campaign lists clinician visits, medication, dose increases, shipping and supplies as included
  • The weight-loss campaign advertises no automatic renewal for the annual offer

What to consider

  • The lowest advertised monthly equivalents require paying for 12 months at once
  • The refund policy describes a possible $100 clinical fee after medical ineligibility, despite the sales-page full-refund promise
  • The pages checked did not name the dispensing pharmacy for an individual order
Harbor

Site position #94 · C

Factor scores not reassessed.

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

What to consider

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard